Search

ALL PSYCHEDELIC AND PSYCHEDELIC STOCK NEWS

Silo Pharma (SILO) Issues Letter to Shareholders

2023 Watch List Editor | Curator -
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine LIVE QUOTE
View Post

Silo Pharma (SILO) $3.36 Achieves New Milestone for SP-26 Therapeutic -Initiates IND Enabling Study of Topical Ketamine Formulation

Featured Editor | Curator -
View Post ENGLEWOOD CLIFFS, NJ, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage...
View Post

Silo Pharma (SILO) Attends Dawson James Conference.

CLINICAL TRIALS Editor | Curator -
We watched an excellent presentation from management at the Dawson conference and starting our due diligence now....
View Post

‘Magic Mushroom’ Psychedelic may Help Heavy Drinkers Quit (AP News)

PSYCH NEWS Editor | Curator -
Psychedelic Drug Helped People with Alcohol use Disorder Reduce Drinking, Study Shows (Today) Psilocybin,...
View Post

Stan Grof, Psychedelic’s Elder Statesman.

INTERVIEW Editor | Curator -
Stan Grof — Lessons from ~4,500 LSD Sessions and Beyond https://youtu.be/3mdYUmvTeig PLAYLIST
View Post

PharmaTher (PHRM, PHRRF) $0.10 Gets $3.80 Price Target From H.C. Wainwright – 37 Times (3,700%) Higher.

RESEARCH Editor | Curator -
Thus, to us, the key potential positive events that could lead to a rerating in PHRM.CN shares include publication of the Phase...
View Post

Ehave, Inc. Announces its KetaDASH Mobile Unit Delivered to Miami Beach.

CLIENT Editor | Curator -
MIAMI, June 03, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced...
View Post

Australian Icannex (IHL:ASX) Headed to NASDAQ?

Featured Editor | Curator -
Incannex completes Phase 2 trial for its cannabinoid drug for sleep apnea, flags Nasdaq listing in 2022
View Post

Testimonial: The Ibogaine Clinic, Playa Del Carmen

TESTIMONIALS Editor | Curator -
VIDEO TESTIMONIALS https://youtu.be/hrrLoxuR2oo VISIT WEBSITE
View Post

Mycotopia Therapies (TPIA) $1.65, Issues CEO Letter to Stockholders, Reports on Significant Progress and Outlook for 2021

CLINICS Editor | Curator -
Mycotopia Therapies looking to unlock the full potential of psychedelic-derived medicines; Create Active Pharmaceutical Ingredient (API) for magic mushroom
View Post

Coming This Monday

CONFERENCES Editor | Curator -
Microdose’s Wonderland: Miami Conference to be held at the Adrienne Arsht Center for the Performing Arts in Miami, FL on November 7-9,...
View Post

Small Pharma (DMT, DMTTF) $0.46 a Small and Extremely Interesting Psychedelic Company.

INTERVIEW Editor | Curator -
Conference Call Today at 12:00 EST. As the TSX chart above show, investors appear to be warming up the...
View Post

Mindcure (MCURF) and Awakn Life Sciences (AWKNF) Seek to Distribute Ketamine Protocol for Alcohol Use Disorder.

CLINICS Editor | Curator -
MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada...
View Post
1...345...11Page 4 of 11

KetaDash

Ketamine at Home Treatments
RESEARCH

Most Popular

Mystery Solved. Threshold Bioscience’s Neuroblo-Ibogaine!

Featured Editor | Curator -
500mg Iboga Total Alkaloid (TA) Extract. Someone posted this photo on LinkedIn, which we took as a tease....

$400 Million Man Tries Psychedelic Toads.

TESTIMONIALS Editor | Curator -
"This was the most profound experience of my life. I am stunned beyond comprehension. This molecule is without peer."

Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36

Featured Editor | Curator -
The Montgomery-Asberg Depression Rating Scale. We were flying from Hawaii to Las Vegas yesterday and when we landed,...

LARGE CAP PSYCHEDELIC STOCKS

PSYCHEDELIC FUNDS AND ETFS

Copyright Revelers,io Media for Instiutional Analyst Inc.